Pharmacy Times

JULY 22, 2025

Compounding this issue, many pharmacies face ongoing staffing shortages, which hinder efficient operations and compromise the ability to deliver quality patient care. These deserts reduce access to critical health care services, such as vaccinations, health screenings, and point-of-care testing.

Pharmacy Technician

Pharmacy Times

JUNE 27, 2025

Patients often present with peripheral blood, bone marrow, and splenic involvement. 5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. There is currently no universal standard of care for MCL.

Pharmacy Technician

Express Pharma

JANUARY 2, 2025

The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in 2023 to $9.9

Diabetes

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Pharmacy Technician

Pharmacy Times

JUNE 12, 2025

The increasing use of herbal supplements among patients undergoing cancer treatment, particularly those on oral therapies, presents a significant and often unaddressed challenge in oncology care. A total of 40 different herbal supplements were identified, and use was primarily through medication reconciliation.

Pharmacy Technician

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations. REFERENCES 1.

Pharmacy Technician

Pharmacy Times

JUNE 13, 2025

During an earlier presentation, Klepser states that there are 150 US counties that do not have a pharmacy or pharmacist. Presented at: American Association of Pharmacy Technicians 2025 Annual Pharmacy Technician Convention. It is absolutely crucial to know how we might get to a point where this is actually a business model. Denver, CO.

Pharmacy Technician

Pharmacy Times

AUGUST 14, 2025

1-4 Image credit: Semi | stock.adobe.com Pharmacists need to remember a few clinical pearls when patients present with prescriptions for SGLT2 inhibitors. Again, SGLT2 inhibitors cause osmotic diuresis that usually presents as thirst, polyuria, lightheadedness, or fatigue. Clinical Pearl No.

Diabetes

Pharmacy Times

JUNE 16, 2025

1 The findings were presented at the Revolutionizing Atopic Dermatitis (RAD) 2025 conference held in Nashville, Tennessee. The results confirm nemolizumab’s use in increasing improvements in symptoms, such as itch and skin lesions, with prolonged treatment up to 2 years.

Pharmacy Technician

Pharmacy Times

JUNE 25, 2025

Despite its proven efficacy, the conventional oral administration of lenalidomide presents challenges due to its short half-life and the high systemic exposure required to sustain therapeutic drug levels, which can lead to significant toxicities, particularly grade 3 or 4 hematologic adverse events (AEs).

Pharmacy Technician

Pharmacy Times

JULY 12, 2025

Presented at: McKesson ideaShare 2025. Find an example of someone who’s doing it somewhere else, and I’m willing to bet they’ll take the time to sit down and help you figure out how to make it work in your state.” REFERENCES 1. Kinsey JD, Meredith A, Novak N, Howard M. Nashville, TN; July 11, 2025. News release.

Pharmacy Technician

GMPSOP

JUNE 15, 2025

In manufacturing environments where living cells are used, such as biological products like vaccines, manufacturers generally include a virus reduction step in their processes. Bacteria and fungi also play important roles in the consumer and pharmaceutical industry, for instance, in the production of food, vaccines, and antibiotics.

Pharmaceutical Manufacturing

Pharmacy Times

JULY 19, 2025

While the results of this study were presented at the American College of Cardiology meeting in 2023, the completed study results have yet to be published. The addition of beta blockers or other drug classes are indicated when BP goals are not achieved or if concomitant comorbidities are present.

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 14, 2025

The designation follows positive results from the ongoing BEACON phase 1/2 clinical trial (NCT05456880), which were presented at the 2025 European Hematology Association (EHA) Congress. The enrolled patients required a median of 1 mobilization cycle (range: 1–3 cycles).

Pharmacy Technician

Pharmacy Times

JUNE 11, 2025

Image Credit: © Chinnapong - stock.adobe.com At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025, an encore presentation from the Pacific Coast Reproductive Society Annual Meeting will highlight findings from a retrospective analysis conducted by Walgreens Specialty Pharmacy.

Pharmacy Technician

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. AON Pharmacy's interventions saved $1.9 million by withholding shipments due to therapy changes or patient status.

Mail-Order Pharmacies

Pharmacy Times

JUNE 20, 2025

Pharmacy Times: What are some key sessions that will be presented at the upcoming 2025 ADA Scientific Sessions? Pharmacy Times: What role do you see pharmacists playing in the discussions and advancements presented at the event? Isaacs : I am so excited for the ADA Scientific Sessions. It is my favorite meeting of the entire year.

Diabetes

Pharmacy Times

JULY 22, 2025

When you are enjoyable to work with, reliable, organized, and do impactful work, your name often comes up in spaces where you’re not present, opening doors to new partnerships. Strong collaborations lead to opportunities. It’s a cycle of trust and shared success, and I’ve been fortunate to benefit from and contribute to it.

Pharmacy Technician

Pharmacy Times

JUNE 12, 2025

Biologics Versus Biosimilars Biologics Image credit: lexiconimages | stock.adobe.com Darkow begins the presentation by describing biologics as a large, complex molecule that is made of living sources, such as bacteria, yeasts, and animal cells. Unlike other medications and treatments, they are not chemically synthesized.

Biosimilars

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share what you presented at the 2025 OPC meeting? My role is really about using my expertise with medications to support decision-making based on data, like abstracts presented at meetings like this one, to ensure patients receive the best possible treatment.

Pharmacy Technician

Pharmacy Times

JULY 22, 2025

Alixorexton presents as a hopeful, potentially paradigm-shifting treatment for this population. OX2Rs play a critical role in the maintenance of wakefulness in patients with NT1, which is characterized by the loss of orexin-producing neurons in cerebrospinal fluid.

Pharmacy Technician

Pharmacy Times

AUGUST 2, 2025

Role of PCP Counseling for Observers Fasting may present risks to post-metabolic and bariatric surgery (MBS) patients. About the Author Amy C. Nieto is a 2026 PharmD Candidate at the University of Connecticut School of Pharmacy in Storrs, CT.

Diabetes

Pharmacy Times

JULY 4, 2025

Patients with inflammatory conditions achieved similar clinical outcomes after switching from the reference adalimumab (Humira; AbbVie) to a biosimilar, according to real-world data presented at the 2025 American Society of Health-System Pharmacists Pharmacy Futures Meeting. 1 REFERENCES 1. Mountain J, DaCosta SS, Zuern A. (38-M) June 7–11.

Biosimilars

Pharmacy Times

JUNE 26, 2025

The findings, published in The New England Journal of Medicine and presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois, demonstrated that 10 of the 12 treated individuals no longer needed insulin treatment in a 1-year follow-up. Subscribe Now!

Diabetes

Pharmacy Times

AUGUST 14, 2025

4 There are different types of SPS based on clinical and physical presentation. Magnetic resonance imaging of the brain and spinal cord is also commonly performed to exclude structural or demyelinating diseases that could present similar symptoms. Treatment options often require trial, monitoring, and adjustment as needed.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 23, 2025

Presented at: Hematology/Oncology Pharmacy Association 2025 Annual Conference; April 9-12, 2025; Portland, OR. If the request doesn’t come in, all 505(b)(2) drugs will be considered nontherapeutically equivalent and therefore get their own J-code. That’s the system we are headed into very rapidly.” REFERENCE Soefje SA.

Pharmacy Technician

Pharmacy Times

JULY 23, 2025

Understanding and addressing these emotional barriers may present an opportunity to improve adherence and long-term engagement. For patients beginning treatment with immunology biologics or other specialty medications, the transition can be daunting, involving new routines, adverse effect concerns, and evolving perceptions of illness.

Specialty Pharmacies

Pharmacy Times

JULY 31, 2025

Despite reduced prevalence of targeted serotypes, vaccine serotypes persist, necessitating future vaccine development. SHOW MORE Both vaccine and non-vaccine serotypes were identified as being resistant to critical antimicrobial treatments for pneumococcal disease.

Pharmacy Technician

Pharmacy Times

JUNE 9, 2025

Abuse Deterrent Pharma, LLC (ADP), has licensed the LIMITX technology from Acura Pharmaceuticals for a number of pharmaceutical compounds. trillion economic impact in 2020. trillion economic impact in 2020. trillion economic impact in 2020. However, a new advancement in the marketplace is intended to prevent potential injury or death.

Pharmacy Technician

Pharmacy Times

JULY 2, 2025

Ototoxicity, presenting as tinnitus, hearing loss, dizziness, or vertigo, could occur and can be reversible or permanent. The injection is available at room temperature and does not require compounding, thawing, activation, or dilution. 1 The injection is available in 7 different presentations that range from 0.5

Pharmacy Technician

Pharmacy Times

AUGUST 6, 2025

These data were presented at the 2025 American Academy of Neurology (AAN) Annual Meeting. 2,3 According to the data presented at the AAN session, fremanezumab was observed to significantly reduce monthly migraine days compared with placebo (–2.5 vs –1.4; P =.0210).

Pharmacy Technician

Pharmacy Times

JULY 23, 2025

1 Patient Selection and Management for GLP-1 Therapy With so many GLP-1 options available, pharmacists are essential in counseling patients on available therapies based on their disease presentation, designating proper titrations and dosing schedules, and monitoring potential adverse effects. Banting & Best: the discovery of insulin.

Diabetes

Pharmacy Times

AUGUST 12, 2025

1 Key Point: • Prohibited therapies : ° Live vaccines during treatment and for 6 months post-treatment Drug-Drug Interactions Glofitamab’s immunomodulatory activity raises the potential for interactions with other immunosuppressants, anti-infectives, and hepatically metabolized drugs. month follow-up was 13.5 (7.9-18.5) vs not evaluable (19.2-not

Pharmacy Technician

Pharmacy Times

JULY 9, 2025

1 These data, which were presented at the 2025 American Society of Clinical Oncology Annual Meeting, provide more guidance for clinical oncology pharmacists and oncologists when treating patients with a higher risk of serious infections. At 12 months, 4.8% of patients experienced serious infections, with the incidence increasing to 5.6%

Pharmacy Technician

Pharmacy Times

JUNE 22, 2025

Buse noted that further details would be presented at ADA. 1 Stroke Outcomes Inzucchi presented the stroke outcomes assessed in SOUL, noting that diabetes doubles stroke risk, especially in the presence of elevated A1C. While oral semaglutide reduced MACE by 14%, the reduction in stroke alone was not statistically significant.

Pharmacy Technician

Pharmacy Times

AUGUST 7, 2025

FDA-approved RSV vaccines for adults over 60 provide additional protection, complementing infection control strategies. While RSV symptoms typically present as mild and cold-like, some individuals could develop more severe symptoms like pneumonia.

Long-Term Care Facilities

Pharmacy Times

JULY 22, 2025

The Intersection of AI and Pharmacogenetics The integration of AI technologies with pharmacogenetics presents powerful opportunities for enhancing medication therapy management. Demonstrating improved outcomes and cost-effectiveness helps ensure payer support and broadens access to precision therapies.

Pharmacy Technician